4//SEC Filing
LUCI DAVID P 4
Accession 0001104659-25-010180
CIK 0001736243other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:46 PM ET
Size
5.4 KB
Accession
0001104659-25-010180
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option
2025-02-05+250,000→ 250,000 totalExercise: $0.80Exp: 2035-02-05→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]On February 5, 2025, the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest immediately.
Documents
Issuer
Acurx Pharmaceuticals, Inc.
CIK 0001736243
Entity typeother
Related Parties
1- filerCIK 0001271123
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:46 PM ET
- Size
- 5.4 KB